About Thyrocare
Thyrocare is a company based in Mumbai (India) founded in 1996 by Geetanjali Pundhir and Arokiaswamy Velumani was acquired by API Holdings in June 2021. Thyrocare has raised $63.59 million across 4 funding rounds from investors including API Holdings, The Times Of India and Norwest Venture Partners. The company has 1,950 employees as of March 31, 2024. Thyrocare has completed 2 acquisitions, including Think Health Care and Thinkhealthcare.info. Thyrocare operates in a competitive market with competitors including Vijaya Diagnostic Centre, Suraksha Diagnostics, Krsnaa Diagnostics, Igenetic and Medall, among others.
- Headquarter Mumbai, India
- Employees 1950 as on 31 Mar, 2024
- Founders Geetanjali Pundhir, Arokiaswamy Velumani
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Thyrocare Technologies Ltd
-
Annual Revenue
$80.41 M (USD)20.19as on Mar 31, 2025
-
Net Profit
$10.71 M (USD)29.32as on Mar 31, 2025
-
EBITDA
$22.71 M (USD)35.52as on Mar 31, 2025
-
Total Equity Funding
$63.59 M (USD)
in 4 rounds
-
Latest Funding Round
$1.27 M (USD), Post-IPO
Jun 28, 2017
-
Investors
API Holdings
& 4 more
-
Employee Count
1950
as on Mar 31, 2024
-
Investments & Acquisitions
Think Health Care
& 1 more
-
Acquired by
API Holdings
(Jun 25, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Thyrocare
Thyrocare is a publicly listed company on the NSE with ticker symbol THYROCARE in India, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Thyrocare
Thyrocare has successfully raised a total of $63.59M across 4 strategic funding rounds. The most recent funding activity was a Post-IPO round of $1.27 million completed in June 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Post-IPO — $1.3M
- First Round First Round
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2017 | Amount | Post-IPO - Thyrocare | Valuation |
investors |
|
| Sep, 2012 | Amount | Series B - Thyrocare | Valuation | Norwest Venture Partners |
|
| Dec, 2010 | Amount | Series B - Thyrocare | Valuation | CX Partners |
|
Investors in Thyrocare
Thyrocare has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include API Holdings, The Times Of India and Norwest Venture Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments in financial services, fintech, healthcare, and healthtech sectors in India.
|
Founded Year | Domain | Location | |
|
Venture capital and growth equity firm providing investments and resources to entrepreneurs in various sectors.
|
Founded Year | Domain | Location | |
|
Private equity investments in India are managed by CX Partners.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Thyrocare
Thyrocare has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Think Health Care and Thinkhealthcare.info.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of healthcare services at home
|
2017 | ||||
|
Provides at home ECG testing and primary care options focused on health and wellness for patients with chronic conditions
|
2009 |
Financial Statements - Thyrocare
Thyrocare Comparisons
Competitors of Thyrocare
Thyrocare operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Vijaya Diagnostic Centre, Suraksha Diagnostics, Krsnaa Diagnostics, Igenetic and Medall, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Diagnostic services are offered via a chain of centers.
|
|
| domain | founded_year | HQ Location |
Pathology, molecular diagnostics, and imaging services are provided.
|
|
| domain | founded_year | HQ Location |
Chain of radiology & pathology laboratory centers
|
|
| domain | founded_year | HQ Location |
Provider molecular diagnostic solutions and services
|
|
| domain | founded_year | HQ Location |
Medical diagnostic services are provided through a chain of centres.
|
Frequently Asked Questions about Thyrocare
Thyrocare was founded in 1996 and raised its 1st funding round 10 years after it was founded.
Thyrocare is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Geetanjali Pundhir is the current CEO of Thyrocare. They have also founded this company.
Thyrocare is a funded company, having raised a total of $63.59M across 4 funding rounds to date. The company's 1st funding round was a Series B of $41.01M, raised on Jun 01, 2006.
As of Mar 31, 2024, the latest employee count at Thyrocare is 1,950.
Annual revenue of Thyrocare is $80.41M as on Mar 31, 2025.
Thyrocare was founded in 1996 in Mumbai, India, within the healthcare diagnostics sector. A chain of centers is maintained, providing pathology services, COVID testing, nutritional deficiency screenings, and other diagnostic tests. Operations have expanded from initial thyroid testing to over 350 tests and packages, including 83 profiles for preventive care and wellness under the Aarogyam brand. Services are accessible through the domain thyrocare.com.
Thyrocare's top competitors include Krsnaa Diagnostics, Suraksha Diagnostics and Vijaya Diagnostic Centre.
Yes, Thyrocare is publicly traded on NSE under the ticker symbol THYROCARE.
Thyrocare has made 2 acquisitions, including Think Health Care, and Thinkhealthcare.info.
Thyrocare has 5 investors. Key investors include API Holdings, The Times Of India, Norwest Venture Partners, Sabre Partners India, and CX Partners.
The ticker symbol of Thyrocare is THYROCARE on NSE.